This evidence has also been bolstered by a recent study demonstrating a high prevalence of germline pathogenic variants in ATM relative to other hereditary cancer genes across a spectrum of cancers lacking testing guidelines, including bladder, brain, esophagus, and head and neck cancers (15). The gene discussed is ATM; the disease is cancer.